Skip to Main Content

65: PROSTATE CANCER

Elizabeth E. Demarse, DPT, MTC; Eric Shamus, PhD, DPT, PT, CSCS; Stephanie N. Wright, MOT, OTR/L; Adrian Taylor, DPT

ICD-9-CM CODES1

  • 185 Malignant neoplasm of prostate

  • 233.4 Carcinoma in situ of prostate

ICD-10-CM CODES2

  • C61 Malignant neoplasm of prostate

  • D07.5 Carcinoma in situ of prostate

PREFERRED PRACTICE PATTERNS3

  • 4C: Impaired Muscle Performance

  • 6B: Impaired Aerobic Capacity/Endurance Associated With Deconditioning

PATIENT PRESENTATION

A 73-year-old male presents with intermittent urinary leakage that is worse with activity. He is retired but stays active in his home doing repairs and renovations. He uses a Kotex sized protective pad which he changes once a day. He gets up an average of 2×/night for urination and does not need pad protection with sleep. He complains that Viagra does not help as much with his erection as it did when he first started taking it. He avoids acidic drinks and drinks water throughout the day. He is pending C-pap for his recently diagnosed sleep apnea. He denies any signs or symptoms of infection and has no bowel issues. PMH includes prostate cancer, external beam radiation (XRT) to prostate, erectile dysfunction (uses penile pump and Viagra), urinary leakage s/p XRT, O/A, dyslipidemia, pneumonia, sleep apnea.

Flow cytometry with WNL for fluid retention. Sensation/neurological: patient is able to sense leakage (can have pudendal nerve damage secondary to XRT). MMT: is able to maintain pelvic floor contraction (verbal cue—to engage muscles as if attempting to stop urine flow or draw the testicles inward). First trial: 25 seconds, second: 38 seconds, third: 55 seconds. Quick flicks (engaging and releasing using aforementioned cueing) in 10 seconds. First trial: 3×, second: 3×, third: 5×.

KEY FEATURES

Description

  • Cancer begins in prostate gland

  • Wraps around the urethra

  • 98% of prostatic tumors are adenocarcinomas1

  • Aggressive and slow-growing forms

Essentials of Diagnosis

  • Prostate-specific antigen (PSA) screens

  • Needle biopsy

  • Gleason grade to assess risk of cancer spreading

    • The Gleason scale assigns cancer cells a score from 1 to 10, by combining the two most common patterns of cells to give a total score (i.e., 3 + 4 = grade 7). These scores are broken down into three main levels.

      • Gleason score of 4 or less = Low-grade (well differentiated)

      • Gleason score between 4 and 7 = Intermediate grade (moderately differentiated)

      • Gleason score between 8 and 10 = High-grade (poorly differentiated)

  • ABCD stages of prostate cancer

    • Stage A: Cancer found when not suspected or due to a high PSA level

    • Stage B: Cancer found due to abnormal digital rectal examination and is held in the prostate

    • Stage C: Cancer that has spread to the tissues outside of the prostate

    • Stage D: Cancer that has spread to the lymph nodes or bone

FIGURE 65-1

Organization of the prostate gland. (From Mescher AL. Junqueira’s Basic Histology: Text and Atlas. 12th ed. www.accessmedicine.com. Copyright ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.

This site uses cookies to provide, maintain and improve your experience. MH Privacy Center Close